Piramal Pharma Limited Reports Q3 FY25 Revenue of ₹22.04 Billion

Unknown Apr 02, 2026 650 Views

Piramal Pharma Limited has announced its financial results for the third quarter of the fiscal year 2025, reporting consolidated revenue from operations of ₹22.04 billion. The company continues to focus on its core pharmaceutical segments, including Pharma Solutions, Critical Care, and Consumer H...

Stay Ahead – Explore Now! PPAP Automotive Partners with Hutchinson for Advanced Body Sealing